Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Combination of gallium citrate and levofloxacin induces a distinct metabolome profile and enhances growth inhibition of multidrug-resistant Mycobacterium tuberculosis compared to linezolid
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi. Department of Microbiology, Virology and Biotechnology, Faculty of Biology, Odesa I.I. Mechnikov National University, Odesa, Ukraine.
Odesa Center for Socially Significant Diseases of Odesa Regional Council, Odesa, Ukraine.
Department of Microbiology, Virology and Biotechnology, Faculty of Biology, Odesa I.I. Mechnikov National University, Odesa, Ukraine.
Department of Microbiology, Virology and Biotechnology, Faculty of Biology, Odesa I.I. Mechnikov National University, Odesa, Ukraine.
Visa övriga samt affilieringar
2024 (Engelska)Ingår i: Frontiers in Microbiology, E-ISSN 1664-302X, Vol. 15, artikel-id 1474071Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Introduction: Tuberculosis (TB) treatment typically involves a tailored combination of four antibiotics based on the drug resistance profile of the infecting strain. The increasing drug resistance of Mycobacterium tuberculosis (Mtb) requires the development of novel antibiotics to ensure effective treatment regimens. Gallium (Ga) is being explored as a repurposed drug against TB due to its ability to inhibit Mtb growth and disrupt iron metabolism. Given the potential interactions between Ga and established antibiotics, we investigated how a combination of Ga with levofloxacin (Lfx) or linezolid (Lzd) affects the growth and metabolome of a multidrug-resistant (MDR) Mtb clinical strain.

Methods: Mtb was cultured using a BACTEC 960 system with concentrations of Ga ranging from 125 to 1,000 μM and with 250 to 500 μM of Ga combined with 0.125 mg/L of Lfx or Lzd. For metabolome analysis, the antibacterials were used at concentrations that inhibited the growth of bacteria without causing cell death. Metabolites were extracted from Mtb cells and analyzed using chromatography-mass spectrometry.

Results: The MDR Mtb strain exhibited a dose-dependent response to Ga. Notably, the enhancement in growth inhibition was statistically significant for the Ga/Lfx combination compared to Ga alone, while no such significance was observed for Ga/Lzd. Moreover, exposure to Ga/Lfx or Ga/Lzd resulted in distinct metabolite profiles. Ga treatment increased the level of aconitate, fumarate, and glucose in the cells, suggesting the inhibition of iron-dependent aconitase and fumarate hydratase, as well as disruption of the pentose phosphate pathway. The levels of glucose, succinic acid, citric acid, and hexadecanoic acid followed a similar pattern in cells exposed to Ga and Ga/Lfx at 500 μM Ga but exhibited different trends at 250 μM Ga.

Discussion: In the presence of Lfx, the Mtb metabolome changes induced by Ga are more pronounced compared to those observed with Lzd. Lfx affects nucleic acids and transcription, which may enhance Ga-dependent growth inhibition by preventing the metabolic redirection that bacteria typically use to bypass iron-dependent enzymes.

Ort, förlag, år, upplaga, sidor
Frontiers Media S.A., 2024. Vol. 15, artikel-id 1474071
Nyckelord [en]
levofloxacin, metabolome, drug resistance, central metabolism, Mycobacterium tuberculosis, gallium, linezolid, drug–drug interaction
Nationell ämneskategori
Infektionsmedicin Mikrobiologi inom det medicinska området
Identifikatorer
URN: urn:nbn:se:umu:diva-232554DOI: 10.3389/fmicb.2024.1474071ISI: 001379467900001PubMedID: 39697659Scopus ID: 2-s2.0-85212408140OAI: oai:DiVA.org:umu-232554DiVA, id: diva2:1917701
Forskningsfinansiär
EU, Europeiska forskningsrådetKempestiftelsernaScience for Life Laboratory, SciLifeLabTillgänglig från: 2024-12-03 Skapad: 2024-12-03 Senast uppdaterad: 2025-01-08Bibliografiskt granskad

Open Access i DiVA

fulltext(1988 kB)78 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1988 kBChecksumma SHA-512
9757492a782c49dac8f4a9e8a0eea0c8fed715c362f7e17a4b68ae37390a83a8919d3ed3c0ad8213e4e724c5c1fdbb9820f9808618d7d0c18d2e42b1430e048e
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Ilchenko, OleksandrRamstedt, MadeleineRzhepishevska, Olena

Sök vidare i DiVA

Av författaren/redaktören
Ilchenko, OleksandrRamstedt, MadeleineRzhepishevska, Olena
Av organisationen
Institutionen för klinisk mikrobiologi
I samma tidskrift
Frontiers in Microbiology
InfektionsmedicinMikrobiologi inom det medicinska området

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 78 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 263 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf